Navigating Regulatory Hurdles: Labquality Supports Biomendex in CE Marking Journey for Adaptos® Ortho Wedge
Biomendex has developed an innovative synthetic bone graft substitute called Adaptos® for orthopedic application. This adaptable bone graft composite holds potential across various indications, including orthopedic, spinal and oral & maxillofacial surgeries.
Customer reference
Adaptos® requires CE certification and for that, Adaptos® is now evaluated in clinical investigation. Biomendex has chosen Labquality as their CRO partner for their randomized, controlled, multi-center clinical investigation to evaluate Adaptos® Ortho Wedge Bone Graft Substitute, indicated for high tibial osteotomy, a procedure for correcting knee malalignment.
The development of a high-risk class implantable medical device within a heavily regulated environment inevitably presents challenges for the project. Labquality is working on clinical evaluation, monitoring, data management, GDPR compliance and trial master file for Biomendex, thereby supporting the collection of clinical data necessary for market access of this medical device.
“This is an exciting time as our team at Biomendex has successfully advanced towards CE marking by launching this pivotal clinical investigation and is navigating the challenges with Labquality to achieve this significant milestone,” says Biomendex Ltd. CEO Pasi Kankaanpää.
The first site has been opened at Helsinki University Hospital, where also recruiting the first patients is taking place. As the first stage of the investigation proceeds, additional sites will be opened for recruitment.
About
Biomendex works to enhance tissue technology and manufactures superior medical devices. Learn more about Biomendex
Related Services
Contact us for more information
Leave a contact request
Latest news
Meet us at RAPS in Berlin on May 6-8!
Visit our booth TB1 in the RAPS exhibition and hear about regulatory affairs services for and MD/IVD manufacturers.Meet us in Tomar, Portugal
Labquality will attend SPML's (Sociedade Portuguesa de Medicina Laboratorial) 16th scientific meeting in Tomar, Portugal, from 12 to 13 April 2024.Meet us at ECCMID in Barcelona
Visit our booth E5 in the ECCMID exhibition and hear about EQA services for microbiology, as well as CRO services for pharmaceuticals and MD/IVD manufacturers.Why Modeling Data Flows Is Needed in Clinical Investigations
data management manager explains how data flow modeling will help keep clinical investigation stakeholders informedEQA Coordinator Anna-Riitta Vanhanen Retires After 34 Years of Service
EQA Coordinator Anna-Riitta Vanhanen is retiring in the autumn of 2024 after working at Labquality since 1990. Biochemist Hanna Heikkilä will take over Anna-Riitta's EQA rounds.Subscribe to our newsletter
Subscribe to hear the latest news in the industry and keep track of what's happening behind the scenes.